ZS801

· Institute of Hematology & Blood Diseases Hospital, China

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ZS801, covering 2025-02-24 to 2025-02-24. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients. [NA]